Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 652 of 6351
-
Which surgery is safer for a dangerous placenta condition?
Disease control CompletedPlacenta accreta rates are rising alongside the rising rates of caesarean deliveries. This has lead to a vast number of studies negotiating the histopathological nature, risk factors and outcomes of pregnancies complicated with placenta accreta. In the study the investigators re …
Sponsor: Cairo University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug aims to shrink hard-to-treat GI tumors
Disease control OngoingResearchers are looking for new ways to treat certain types of advanced gastrointestinal (GI) cancers. The study medicine raludotatug deruxtecan (also called MK-5909, R-DXd, or DS-6000a) is a type of medicine called an antibody-drug conjugate (ADC). An ADC attaches to a protein o…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Shock wave device aims to smash heart artery calcium
Disease control OngoingA prospective, single-arm, open-label, multi-center IDE study with up to 55 US sites
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could your own bone marrow cells save your hip from collapse?
Disease control Recruiting nowOsteonecrosis of the femoral head (ONFH) is a debilitating musculoskeletal disease that is characterized by localized death of bone cells and associated cellular elements within the subchondral bone. If it progresses, it results in the collapse of the femoral head (ball part of t…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Neck bypass surgery aimed at flushing out Alzheimer's toxins begins human testing
Disease control Recruiting nowAlzheimer's disease (AD), one of the most common causes of dementia in Singapore and the developed world, is a neurodegenerative disorder with high socioeconomic impact. Accumulation of neurotoxic proteins (ie. amyloid, tau) are purported to lead to neuroinflammation, synaptic dy…
Sponsor: Vincent Tay Khwee Soon • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New study uses DNA and phone data to predict suicide attempts
Knowledge-focused Recruiting nowThe goal of this protocol for an observational retrospective multi-site cohort study is to develop a predictive algorithm for suicidal behavior integrating genetic risk markers, digital phenotypes, and exposomic data in people with a lifetime history of suicide attempt. Participa…
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New DNA test could spot hidden TB in chest fluid, reducing invasive procedures
Diagnosis Recruiting nowTuberculosis (TB) is one of the major global health threats and is the second leading infectious cause of death after COVID-19 in 2022. Extrapulmonary TB (EPTB), amongst which tuberculous pleuritis (TBP) is one of the most common subtypes, poses additional obstacles to global TB …
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
New program aims to protect kids from sexual abuse in sports
Prevention Recruiting nowUsing a matched cluster randomized control design, the proposed study will evaluate a child sexual abuse (CSA) primary prevention strategy, Circles of Safety®. League leadership, staff, and coaches within youth sports will be focal participants. Outcomes include CSA among youth a…
Sponsor: Center for Violence Prevention Research Inc • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Radiation boosts new drug against tough lymphoma?
Disease control Recruiting nowGlofitamab has shown efficacy and safety in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) and has been approved for marketing in China. However, in patients with baseline high tumor burden, the complete response (CR) rate is relative…
Phase 2 • Sponsor: Liling Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can an AI agent match expert urologists? a major test begins
Diagnosis Recruiting nowUrological diseases such as urinary stones, prostate cancer, and bladder cancer are very common and often require highly specialized diagnosis and treatment. Today, the quality of care can vary between doctors, and there are not enough urology specialists to meet patient demand. …
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Which surgery unlocks a locked jaw? a Head-to-Head test
Disease control Recruiting nowThe goal of this clinical trial is to compare the intervention arthroscopic lysis and lavage to the intervention arthrocentesis in treating disabling and painful temporomandibular joint disc displacement without reduction. The main questions it aims to answer are: * Which surgic…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Immunotherapy plus chemo shows promise for esophageal cancer in early trial
Disease control Recruiting nowThis study is a prospective, observational clinical study. In this study, 30 patients with resectable locally advanced esophageal squamous carcinoma will be prospectively enrolled and treated with adebrelimab (SHR-1316) combined with nab-paclitaxel and cisplatin preoperatively an…
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could olive juice compounds help shield the aging brain?
Prevention Recruiting nowNutrition is an important modifiable risk factor of human cognitive health. Increasing data suggests that certain nutrients or food ingredients, such as plant polyphenols, have the potential to benefit cognitive abilities even in later life. In terms of polyphenols, Hydroxytyroso…
Sponsor: Panhellenic Federation of Alzheimer's Disease and Related Disorders • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New injection shows promise for shedding pounds in major trial
Disease control OngoingThis study is a multicenter, randomized, double-blind, placebo-controlled Phase IIb/III clinical trial aimed at evaluating the efficacy, safety, pharmacokinetics (PK), and immunogenicity profile of Efsubaglutide Alfa injection in overweight and obese subjects. The primary endpoin…
Phase 2/3 • Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Stroke recovery breakthrough? new study tests simple blood flow trick
Disease control Recruiting nowAcute ischemic stroke (AIS) is the most common type of stroke, with high incidence rate and mortality. Endovascular therapy is currently the most effective treatment for AIS with large vessel occlusion, but only about 50% of patients achieve good outcome after endovascular therap…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Stenting may offer new hope for tough stroke cases
Disease control Recruiting nowThe goal of this international, multi-center, randomized clinical trial is to compare two treatment options, early intracranial stenting and continued stent-retriever or aspiration based endovascular treatment, for stroke patients with a large vessel occlusion, who experienced fa…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for advanced cervical cancer: drug trial targets remaining risk
Disease control OngoingThis is a phase II single-arm open-label study to investigate the efficacy and safety of volrustomig in women with FIGO 2018 stage IIIA to IVA cervical cancer who have not progressed following platinum-based concurrent chemoradiation therapy (CCRT).
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Hands-free robot suit lets people with spinal cord injury walk and do daily tasks
Disease control Recruiting nowThis study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
Sponsor: Wandercraft • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New Dual-Target CAR-T therapy takes on tough blood cancers
Disease control Recruiting nowThis multicenter phase 1 trial with "3 + 3" dose escalation design seeks to examine the feasibility and safety of the administration of autologous T cells that have been modified through the introduction of chimeric antigen receptors targeting the B cell surface antigens CD19/20/…
Phase 1 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immunotherapy plus chemo before surgery: a new hope for breast cancer?
Disease control Recruiting nowA Prospective, Multicenter, Randomized Controlled Phase II Study to Evaluate the Efficacy and Safety of Adebrelimab Combined with Chemotherapy with or without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC